A detailed history of Lakewood Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lakewood Asset Management LLC holds 730 shares of LLY stock, worth $560,464. This represents 0.44% of its overall portfolio holdings.

Number of Shares
730
Previous 729 0.14%
Holding current value
$560,464
Previous $660 Million 2.13%
% of portfolio
0.44%
Previous 0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$772.14 - $960.02 $772 - $960
1 Added 0.14%
730 $646 Million
Q1 2024

Apr 22, 2024

SELL
$592.2 - $792.28 $65,142 - $87,150
-110 Reduced 13.11%
729 $567 Million
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $350 - $468
1 Added 0.12%
839 $393 Million
Q1 2023

Apr 13, 2023

SELL
$310.63 - $364.82 $4,348 - $5,107
-14 Reduced 1.64%
838 $288 Million
Q4 2022

Mar 01, 2023

BUY
$321.55 - $374.67 $273,960 - $319,218
852 New
852 $312 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lakewood Asset Management LLC Portfolio

Follow Lakewood Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakewood Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lakewood Asset Management LLC with notifications on news.